19/30368988 DC - BS EN ISO 11979-5. Ophthalmic implants. Intraocular lenses. Part 5. Biocompatibility

Find Similar Items

This product falls into the following categories.

You may find similar items within these categories by selecting from the choices below:

19/30368988 DC

BS EN ISO 11979-5. Ophthalmic implants. Intraocular lenses. Part 5. Biocompatibility

Status : Current, Draft for public comment   Published : June 2019

Format
PDF

Format
HARDCOPY



This part of ISO 11979 specifies particular requirements for the biocompatibility evaluation of materials for intraocular lenses (IOLs) including the processing conditions to produce them. These requirements include evaluation of physicochemical properties that are relevant to biocompatibility. It also gives guidance on conducting an ocular implantation test.




Standard Number19/30368988 DC
TitleBS EN ISO 11979-5. Ophthalmic implants. Intraocular lenses. Part 5. Biocompatibility
StatusCurrent, Draft for public comment
Publication Date04 June 2019
Cross ReferencesISO 10993-17, ISO/TS 21726, ISO 10993-1, ISO 10993-10, ISO 10993-6, ISO/TR 22979, ISO 11979-3, ISO 10993-5, ISO 10993-12, ISO 10993-3, ISO 11979-2, ISO 10993-2, ISO 14971, ISO 11979-1, ISO 18369-4:2006
International RelationshipsISO/DIS 11979-5
Draft Expiry Date24 July 2019
DescriptorsPhysical testing, Lenses, Optics, Chemical analysis and testing, Biocompatibility, Eyes, Biological analysis and testing, Ophthalmic equipment, Ophthalmology
ICS11.040.70
Title in FrenchImplants ophtalmiques — Lentilles intraoculaires — Partie 5: Biocompatibilité Partie 5: Biocompatibilité
CommitteeCH/172/7
PublisherBSI
FormatA4
DeliveryYes
Pages35
File Size514 KB
NotesWarning: this draft is not current beyond its expiry date for comments.
Price£20.00


 Your basket
Your basket is empty

Multi-user access to over 3,500 medical device standards, regulations, expert commentaries and other documents


Worldwide Standards
We can source any standard from anywhere in the world


BSOL

The faster, easier way to work with standards


Collaborate, Innovate, Accelerate.